MONDAY, FEBRUARY 18,2019
Episode #61 of 534
Commonwell Health Alliance's Jitin Asnaani on Mission for National Health Data Exchange
This week, hosts Mark Masselli and Margaret Flinter speak with Jitin Asnaani, Executive Director of the CommonWell Health Alliance which is on a mission to make a nationwide health data exchange a reality. They discuss the national network of payer, provider and EHR vendors joining the Alliance to advance interoperability across multiple electronic health record platforms with health data flowing seamlessly from patient to providers.
MONDAY, FEBRUARY 11, 2019
Episode #62 of 534
Clear Health Costs Founder Jeanne Pinder Seeks to Unmask Healthcare's High Costs With Online Price Check Tool
This week hosts Mark Masselli and Margaret Flinter speak with Jeanne Pinder, Founder and CEO of Clear Health Costs, which seeks to unmask the true cost Americans pay for health care. They discuss the online platform she created that compares prices for hospitalizations and procedures offering consumers real transparency in health pricing, utilizing crowd sourced patient payment data vetted by journalists around the country.
MONDAY, FEBRUARY 4, 2019
Episode #63 of 534
Continued Quest for Equity in Health: Thoughts from Morehouse School of Medicine Founder and former HHS Secretary Dr. Louis Sullivan
This week on Conversations on Health Care, hosts Mark Masselli and Margaret Flinter speak with Dr. Louis Wade Sullivan, Founding Dean and President Emeritus of the Morehouse School of Medicine, and former HHS Secretary under the first Bush Administration. Dr. Sullivan discusses his efforts to build diversity in the health professions through his organization, the Sullivan Alliance, and his contributions to building equity in health systems around the country and the world.
MONDAY, JANUARY 28, 2019
Episode #64 of 534
Purdue Pharma and the Opioid Epidemic: Writer Barry Meier Unveils OxyContin's Pivotal Role
This week, hosts Mark Masselli and Margaret Flinter speak with Pulitzer Prize winning writer Barry Meier, author of "Pain Killer: An Empire of Deceit and the Origin of America's Opioid Epidemic," on Purdue Pharma, makers of the narcotic OxyContin, and the pivotal role they played in "the greatest public health crisis of the 21st Century."
MONDAY, JANUARY 21, 2019
Episode #65 of 534
Susannah Fox, Former Chief Technology Officer at HHS, Analyzes Young Consumers' Push Towards Digital Health
This week hosts Mark Masselli and Margaret Flinter speaks with renowned health industry analyst Susannah Fox who served as Chief Technology Officer at the US Department of Health and Human Services. Ms. Fox has been studying the growing impact of the internet on health care and discusses her recent report on how young health consumers are accelerating the adoption of digital technologies in the health care experience.
MONDAY, JANUARY 14, 2019
Episode #66 of 534
Flint Water Crisis Whistle Blower Dr. Mona Hanna-Attisha on the Aftermath of the Poisoning of a City
This week, hosts Mark Masselli and Margaret Flinter speak with Pediatrician and public health activist, Dr. Mona Hanna-Attisha, who exposed the Flint Water Crisis brought on by state and city officials who switched Flint's water supply. She discusses her book on the crisis, "What the Eyes Don't See: A Story of Crisis, Resistance and Hope in an American City" which exposes government efforts to deny their role, and the ongoing community-wide effort to address the public health crisis.
MONDAY, JANUARY 7, 2019
Episode #67 of 534
AI, Blockchain and Cybersecurity: HIMSS CEO Hal Wolf on Topics Dominating Upcoming Global Conference
This week, hosts Mark Masselli and Margaret Flinter speak with Hal Wolf, President and CEO of HIMSS - the Health Information Management Systems Society which seeks to advance information technology in health care. He discusses the upcoming HIMSS 2019 Global Conference, the largest gathering of its kind in the world on topics such as Artificial Intelligence, Voice Technology, Cybersecurity and Blockchain which are expected to dominate this year's event.
MONDAY, DECEMBER 31, 2018
Episode #68 of 534
Starting 2019 Right, Lifestyle as Medicine: Dr. David Katz on Power of Nutrition in Prevention and Health
This week, hosts Mark Masselli and Margaret Flinter speak with Dr. David Katz, globally renowned lifestyle medicine expert and Director of Yale University's Prevention Research Center where his research focuses on advancing diet and nutrition as a powerful tool to reduce the burden of chronic disease. The founder of the True Health Initiative, he discusses his most recent book, "The Truth About Food", a comprehensive reference book for clinicians and patients on the science of nutrition.
MONDAY, DECEMBER 24, 2018
Episode #69 of 534
Best of 2018: AI, CRISPR, Telemedicine, and Emerging Health Care Trends
This week, hosts Mark Masselli and Margaret Flinter look back at some of the most memorable guests from 2018, which included thought leaders in areas such as CRISPR gene editing technology, Artificial Intelligence and Voice in health care, the rise of innovative care delivery models as well as the transformation in health profession training. They also welcomed award-winning investigative journalists who exposed the dark side of the health industry in which corporations profited from defrauding the public and putting patients' lives at risk, from the Theranos scandal to the industry-driven opioid crisis.
MONDAY, DECEMBER 17, 2018
Episode #70 of 534
Fitbit Medical Director Dr. John Moore on Wearable Tech Company's New Personalized Health and Fitness Coaching Platform
This week, hosts Mark Masselli and Margaret Flinter speak with Dr. John Moore, Medical Director of Fitbit, on their newly launched Fitbit Care - a digitally supported personal health and fitness coaching platform that provides personalized support 24/7. Dr. Moore talks about the platform's ability to help participants set achievable goals, linking their real time data to health coaches through their digital technology.
MONDAY, DECEMBER 10, 2018
Episode #71 of 534
National Cancer Institute Director Dr. Norman Sharpless on the Future of Genomics, Prevention, and Personalized Oncology
This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Norman Sharpless, Director of the National Cancer Institute at the National Institutes of Health. They discuss the accelerated pace of discovery in cancer research driven by genomics, big data analytics and personalized oncology. He also stresses the need to address fragmented pockets of research for more rapid deployment of treatment breakthroughs.
MONDAY, DECEMBER 3, 2018
Episode #72 of 534
Microsoft's Voice and AI Evangelist Noelle LaCharite Talks About Transforming Healthcare With Applied AI Coding
This week, hosts Mark Masselli and Margaret Flinter speak with Noelle LaCharite Principal Program Manager for Applied AI and Cognitive Services at Microsoft, and one of the original voice 'skills' developers for Amazon's Alexa. She talks about the promise of applied AI, machine learning and voice technology systems which enable coders, developers or anyone to create their own applications and voice skills to enhance and advance the health care experience.
MONDAY, NOVEMBER 26, 2018
Episode #73 of 534
Researching Medical Marijuana and PTSD: Dr. Sue Sisley on the Quest to Expand Research on the Medicinal Potential of Cannabis
This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Sue Sisley, internist, psychiatrist and President of the Scottsdale Research Institute which is conducting the nation's only FDA-approved study on the efficacy of whole plant marijuana for treatment of PTSD. She discusses her ten-year quest to complete a randomized control trial on the use of cannabis as a potentially effective approach, and restrictions that pose a challenge to expansive scientific research.
MONDAY, NOVEMBER 19, 2018
Episode #74 of 534
National Access to Primary Care and Minister of Loneliness: Dr. Charles Alessi on the UK's Approach to Population Health and Dementia Prevention
This week hosts Mark Masselli and Margaret Flinter speak with Dr. Charles Alessi, Senior Advisor for Dementia Prevention at Public Health England, the UK's equivalent of the CDC. Dr. Alessi talks about the prevention strategies being deployed across the UK to delay the onset of dementia, the lack of barriers to primary care services, and their recently announced Minister of Loneliness to confront this chronic health issue.
MONDAY, NOVEMBER 12, 2018
Episode #75 of 534
Dr. Leana Wen, Day One: Charting Planned Parenthood's Course for Protecting Women's Health
This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Leana Wen, newly appointed President of the Planned Parenthood Federation of American. Dr. Wen talks about successful interventions she launched as Baltimore's Health Commissioner on opioids, maternal mortality and gun violence, planning to take her tough public health approach to addressing challenges to women's health and reproductive rights in America.
MONDAY, NOVEMBER 5, 2018
Episode #76 of 534
Targeted Therapies and Big Cost Savings: Personalized Medicine Coalition President Edward Abrahams on Precision Medicine's Potential
This week, hosts Mark Masselli and Margaret Flinter speak with Edward Abrahams, President of the Personalized Medicine Coalition which supports the emerging science of precision medicine and the huge potential it holds for cost savings with pharmacogenomics, targeted therapies, and improved outcomes for patients and health systems. They discuss the Coalition's upcoming summit at Harvard which will bring together policy makers, leading scientists, advocates and provider organizations to devise strategies for advancing precision medicine.
MONDAY, OCTOBER 29, 2018
Episode #77 of 534
"She Has Her Mother's Laugh" - New York Times Science Writer Carl Zimmer on Heredity and the Genomics Revolution
This week, hosts Mark Masselli and Margaret Flinter speak with award-winning New York Times science writer and columnist Carl Zimmer on his critically acclaimed book, "She Has Her Mother's Laugh: The Powers, Perversions and Potentials of Heredity" on the dramatic scientific discovery underway fueled by genomics. He discusses the genome's role in understanding heredity and how personalized medicine will be advanced once the science and medical communities master their knowledge of how genomics impact health and disease.
MONDAY, OCTOBER 22, 2018
Episode #78 of 534
Mental Health Crisis in America: National Council for Behavioral Health CEO Linda Rosenberg on Causes and Solutions
This week hosts Mark Masselli and Margaret Flinter speak with Linda Rosenberg, CEO of the National Council for Behavioral Health on their recent report done with the Cohen Veterans Network confirming that America's mental health crisis is a result of lack of access to care. She discusses the need to remove barriers to behavioral care, the need to embed behavioral health in primary care and for much better mental health and addiction training for providers and social workers.
MONDAY, OCTOBER 15, 2018
Episode #79 of 534
Climate Report's Dire Warnings: World Health Organization's Dr. Maria Neira on Impact of Pollution and Climate Change on Health
This week, hosts Mark Masselli and Margaret Flinter revisit their conversation with Dr. Maria Neira, Director of Public Health and the Environment at the World Health Organization who addresses the rising threat to human health from climate change and pollution - now the 4th leading cause of death worldwide. She discusses global strategies that are required to reduce the harm being done to populations around the world, especially those most vulnerable, in the wake of advancing climate change and unmitigated pollution.
MONDAY, OCTOBER 8, 2018
Episode #80 of 534
The Political Challenges in American Health Reform: Former CMS Administrator Don Berwick on the Need for Clinician Activism
This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Don Berwick, President Emeritus of the Institute for Healthcare Improvement and former CMS Administrator who oversaw the launch of the Affordable Care Act. He talks about inherent political challenges in American health care, the need for providers to get active politically, and the promise of real innovations in the health system coming from outside the industry.